BeyondSpring Inc.
BYSINext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for BYSI. That does not mean none is planned.
Get an email about BYSI's next catalysts
Track BeyondSpring (BYSI) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 3 past
No catalysts found.
How BYSI's past catalysts played out
Market Overview
Stock performance and key metrics
Docetaxel + Plinabulin (DP)
Non-Small Cell Lung Cancer
Plinabulin
Chemotherapy-induced Neutropenia
Pegfilgrastim
Chemotherapy-induced Neutropenia
Nitric Oxide
Bronchiolitis
Docetaxel (D)
Non-Small Cell Lung Cancer
Docetaxel, doxorubicin, and cyclophosphamide (TAC)
Chemotherapy-induced Neutropenia
Pembrolizumab in Combination with Plinabulin and Docetaxel
Non Small Cell Lung Cancer Metastatic
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Docetaxel + Plinabulin (DP) | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Plinabulin | Phase 3 | Chemotherapy-induced Neutropenia | - | - |
Pegfilgrastim | Phase 3 | Chemotherapy-induced Neutropenia | - | - |
Nitric Oxide | Phase 3 | Bronchiolitis | - | - |
Docetaxel (D) | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Docetaxel, doxorubicin, and cyclophosphamide (TAC) | Phase 2 | Chemotherapy-induced Neutropenia | - | - |
Pembrolizumab in Combination with Plinabulin and Docetaxel | Phase 2 | Non Small Cell Lung Cancer Metastatic | - | - |
Metastatic NSCLC
1 drug in this indication
Advanced or metastatic non-squamous NSCLC without actionable genomic alterations, post-ICI and platinum-based chemotherapy (in combination with docetaxel)
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in BeyondSpring Inc.'s drug pipeline?β
CatalystAlert tracks 7 drug candidates in BeyondSpring Inc.'s (BYSI) pipeline across Phase 3, Phase 2. Its lead program is Plinabulin (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is BeyondSpring Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for BeyondSpring Inc. (BYSI) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track BYSI biotech catalysts?β
Add BYSI to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow BeyondSpring Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
